+Relevance of nitric oxide to the response of tumors to photodynamic therapy

Proceedings of SPIE - The International Society for Optical Engineering

Volumn 3247, Issue , 1998, Pages 98-105

  Korbelik, Mladen ^a   Shibuya, Hiroshi ^a   Cecic, Ivana ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

Inflammatory cells; Ischemia reperfusion injury; Nitric oxide; Photodynamic therapy; Tumor vasculature

Indexed keywords

BIOMATERIALS; CORRELATION METHODS; NITROGEN OXIDES; OXIDATION; STRESS ANALYSIS; TISSUE; TUMORS;

INFLAMMATORY CELLS; OXIDATIVE STRESSES;

PHOTODYNAMIC THERAPY;

EID: 0032224349     PISSN: 0277786X     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1117/12.308136     Document Type: Conference Paper

References (63)

1. Clinical and preclinical photodynamic therapy
2. Photodynamic therapy in oncology: Mechanisms and clinical use
3. How does photodynamic therapy work?
4. Induction of tumor immunity by photodynamic therapy
5. Photochemotherapy of cancer: Basic concepts and clinical applications
6. Nitric oxide: A physiologic messenger molecule
7. NO at work
8. Endothelium and responsiveness of vascular smooth muscle
9. Nitric oxide: An endogenous modulator of leukocyte adhesion
10. The role of nitric oxide in cardiac ischemia-reperfusion injury
11. Nitric oxide in coronary artery disease: Roles in atherosclerosis, myocardial reperfusion and heart failure
12. Nitric oxide as a mediator of inflammation? - You had better believe it
13. Nitric oxide: A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells
14. Nitric oxide increased interleukin-4 expression in T lymphocytes
15. Nitric oxide inhibits the secretion of T-helper 1-and T-helper 2-associated cytokines in activated human cells
16. Feedback inhibition of nitric oxide synthase activity by nitric oxide
17. Intracellular assembly of inducible NO synthase is limited by nitric oxide-mediated changes in heme insertion and availability
18. A novel citruline-forming enzyme implicated in the formation of nitric oxide by vascular endothelial cells
19. Nitric oxide synthases in mammals
20. Nitric oxide synthases: Properties and catalytic mechanism
21. Inhibition of constitutive and inducible nitric oxide synthase: Potential selective inhibition
22. Vasodilator effect of carboxy-2-phenyl-4,4,5,5,-tetramethylimidazoline-1-oxyl in the coronary circulation: In vivo and in vitro studies
23. Complexes of ·NO with nucleophiles as agents for the controlled biological release of nitric oxide. Vasorelaxant effects
24. Nitric oxide in turnout biology and cancer therapy. Part 1: Physiological aspects
25. Nitric oxide synthase activity in human gynecological cancer
26. Nitric oxide activity in human breast tissue
27. Microvascular architecture in a mammary carcinoma: Branching parterre and vessel dimensions
28. Roles of nitric oxide in tumor growth
29. Diminished leukocyte-endothelium interaction in tumor microvessels
30. Nitric oxide involvement in tumor-induced immunosuppression
31. Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis in K-1735 murine melanoma cells
32. Direct correlation between expression of endogenous inducible nitric oxide synthase and regression of M5076 reticulum cell sarcoma hepatic metastases in mice treated with liposomes containing lipopeptide CGP 31362
33. Destruction of bystander cells by tumor cells transfected with inducible nitric oxide (NO) synthase gene
34. Cytokine-induced apoptosis in transformed murine fibroblasts involves synthesis of endogenous nitric oxide
35. Effect of nitric oxide on the radiosensitivity of bacteria
36. Effect of oxidative stress on receptors and signal transmission
37. Role of neutrophils in ischemia-reperfusion-induced microvascular injury
38. A novel cancer therapy based on oxygen radicals
39. Ischemia reperfusion injury in tumors: The role of oxygen radicals and nitric oxide
40. Xanthine oxidase and neutrophil infiltration in intestinal ischemia
41. Molecular mechanisms involved in superoxide-induced leukocyte-endothelial cell interactions in vivo
42. Nitric oxide prevents leukocyte adherence: Role of superoxide
43. The role of nitric oxide in the response of cancerous lesions to photodynamic therapy
44. In situ evidence for the involvement of superoxide anions in cutaneous porphyrin photosensitization
45. A novel mechanism for the generation of superoxide anions in hematoporphyrin derivative-mediated cutaneous photosensitization. Activation of xanthine oxidase pathway
46. Altered expression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivo
47. Systemic immunosuppression induced by photodynamic therapy (PDT) is adoptively transferred by macrophages
48. The role of host lymphoid populations in the response of mouse EMT6 tumor to photodynamic therapy
49. Nitric oxide in biological fluids: Analysis of nitrite and nitrate by high performance ion chromatography
50. Antitumor effect of photodynamic therapy: The role of superoxide, hydrogen peroxide and nitric oxide
51. EPR detection of nitric oxide (·NO) in the phototherapy of minors
52. The role of nitric oxide in the response of solid tumors to photodynamic therapy
53. Photophysical and photobiological processes in the photodynamic therapy
54. Induction of immune cell infiltration into murine SCCVII turnout by photofrin-based photodynamic therapy
55. Photosensitizer distribution and photosensitized damage of tumor tissues
56. Effects of diethylamine/nitric oxide on blood flow perfusion and oxygenation in the R320Ac mammary carcinoma
57. 7]. In situ nitric oxide generation to sensitize γ-radiation induced cell death
58. Nitric oxide synthesis in the CNS, andothelium and macrophages differs in its selectivity to inhibition by arginine analogues
59. Identification of N-iminothyl-L-ornithine as an irreversible inhibitor of nitric oxide synthase in phagocytic cells
60. Aminoguanidine selectively inhibits inducible nitric oxide synthase
61. Cytokine-activated endothelial cells express an isotype of nitric oxide synthase which is tetrahydrobiopterin-dependent, calmodulin independent and inhibited by arginine analogs with a rank order potency characteristic of activated macrophages
62. Inhibitors of nitric oxide synthase selectively reduce flow in tumor-associated neovasculature
63. Effect of nitro-L-arginine on blood flow, oxygenation and the activity of hypoxic cell cytotoxins in murine tumors